LITTLE FALLS, N.J.,
Oct. 16, 2015 /PRNewswire/ --
CANTEL MEDICAL CORP. (NYSE: CMN) announced today that its
Board of Directors approved an increase in its semiannual cash
dividend from $0.05 to $0.06 per outstanding share of the Company's
Common Stock. The dividend is payable on January 29, 2016 to shareholders of record at the
close of business on January 15,
2016.
Charles M. Diker, Chairman of the
Board, said, "We are pleased to announce the increase in our
dividend, which will raise our annual dividend payment from
$0.10 to $0.12 per share. The 20% increase in our dividend
demonstrates Cantel's strong financial position and our confidence
in Cantel's future performance."
Cantel Medical is a leading global company dedicated to
delivering innovative infection prevention and control products and
services for patients, caregivers, and other healthcare providers
which improve outcomes, enhance safety and help save lives.
Our products include specialized medical device reprocessing
systems for endoscopy and renal dialysis, advanced water
purification equipment, sterilants, disinfectants and cleaners,
sterility assurance monitoring products for hospitals and dental
clinics, disposable infection control products primarily for dental
and GI endoscopy markets, dialysate concentrates, hollow fiber
membrane filtration and separation products. Additionally, we
provide technical service for our products.
For further information, visit the Cantel website at
www.cantelmedical.com.
This press release contains forward-looking statements within
the meaning of the Private Securities Litigation Reform Act of
1995. These statements involve a number of risks and uncertainties,
including, without limitation, the risks detailed in Cantel's
filings and reports with the Securities and Exchange Commission.
Such forward-looking statements are only predictions, and actual
events or results may differ materially from those projected or
anticipated.
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/cantel-medical-board-of-directors-authorizes-20-increase-in-semiannual-dividend-300161167.html
SOURCE Cantel Medical Corp.